Pathology Devices Market


Pathology Devices


Share, Global Trends,

Analysis, Research, Report,


Segmentation and Forecast,


Future Market Insights

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and


We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas







Social Media


Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268


Report Description

Pathology is the field in healthcare which provides accurate information regarding the

progression of disease conditions. This information helps physicians to monitor and

manage the therapies. Increasing advances in the diagnostic techniques such as PCR,

biopsies, and other assays have catered to the needs of pathology services across various

domains of healthcare industry. Biomarker technology is one the diagnostic tool which

would get prominent potential in next five years. Such advances in technologies has

largely helped physicians to measure and monitor the progression life style diseases such

as stroke, diabetes and cancer. Other technologies such as immunoassays, clinical

chemistry are also framing the demand for pathology devices to next level. These

technologies are prominently used across developed regions owing to lower cost and

easy availability. However, the substandard quality and marginal efficiency would pose a

threat for these technologies. Pathology devices used in diagnosing infectious diseases,

cancer and other prevalent diseases have high demand across globe. Moreover, devices

used during clinical trials, drug discovery and development are gaining pace owing to

increasing pharmaceutical research and development.

Pathology Devices Market: Drivers & Restraints

Increasing prevalence of chronic diseases, growing number of geriatric population and

active initiatives from the government to regulate preventive measures of infectious

diseases has triggered growth of pathology devices market, globally. The rising incidence

of sexually transmitted diseases and lifestyle diseases is increasing the demand for

anatomical and clinical chemistry pathologies. However, prevalent conditions such as

autoimmune diseases, chromosomal diseases are elevating a need for more advanced

Report Description

Browse Full Report@

Pathology Devices Market: Segmentation

The global pathology devices market is segmented based on, technology, application and

end users.

Based on technology, the global pathology devices market is segmented into the


Immunoassays technology

Clinical chemistry



Molecular diagnostics

Based on application, the global pathology devices market is segmented into the


Disease diagnostics

Drug discovery and development

Forensic diagnostics

Report Description

Based on end users, the global pathology devices market is segmented into the following:

Diagnostics laboratories

Forensic laboratories

Academic institutes

Contract research organizations

Pharmaceutical and biotechnology companies

Request Free Report Sample@

Pathology Devices Market: Overview

By technology, immunoassays and clinical chemistry are two leading segments, owing to

its higher adoption in developing regions. However, molecular diagnostic is expected to

gain pace during the forecast period. This is due to its superior quality over conventional

pathology techniques such as immunoassays and clinical chemistry. By application, the

disease diagnostic was the leading application segment in pathology devices market.

However, drug discovery and drug development is anticipated to grow at a healthy CAGR

during the forecast period. By end users, diagnostic laboratories was the highest revenue

generating segment in 2015. However, pharmaceutical and biotechnology companies and

contract research organizations are expected to be the fastest growing segment during

the forecast period.

Report Description

Pathology Devices Market: Region-wise Outlook

By region, North America was the most dominating region in pathology devices market in

2015, followed by Europe. Favorable government regulations and high affordability are

the prominent factors responsible for the growth of Nprth America & Europe pathology

devices market. Moreover, the growing demand for door step diagnostic services and

advancement in technologies are promoting the growth of pathology devices market in

North America and Europe region. In October 2016, Roche Diagnostics has received US

FDA approval for the cobas HBV and cobas HCV viral load test. This test provide rapid

result with highest throughput in hepatitis B or hepatitis C conditions. Such

commercialization of novel diagnostic tools provides promising growth opportunities for

pathology devices market.

Request For TOC@

Pathology Devices Market: Key Players

Some of the leading players operating in pathology device market are Becton, Dickson

and Company, Ortho-Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, Inc.,

Johnson and Johnson, Danaher Corporation, Ventana Medical Systems, Hamamatsu

Photonics K.K., Mikroscan Technologies, Definiens AG, Visiopharm, Thermo Fisher

Scientific, Inc., Siemens Healthcare, Bio-Rad Laboratories, Inc., Sysmex Corporation,

bioMérieux, 3DHistech, Quest Diagnostics and LabCorp. Receiving commercial approvals

from the respective government authorities plays a crucial role in novel product launch in

the global pathology devices market. Moreover, these companies are majorly focusing on

Thank You!

To know more about us, please visit our website:

For sales queries or new topics email us on:

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines